Assessing Barriers to Heart Transplantation for Bridge to Decision and Long Term Left Ventricular Assist Device Recipients
Introduction: Left ventricular assist device (LVAD) therapy may serve as bridge to heart transplantation (HT) for patients whose initial implant strategy is bridge-to decision (BTD) or destination/long-term therapy (LT).Data capturing modifiable barriers or contraindications to HT and their evolution after LVAD therapy are lacking. Methods:We conducted a single-center observational retrospective cohort study of patients with barriers to HT undergoing LVAD implantation as BTD or LT between 1/1/2014 and UNOS: United Network for Organ Sharing
Authors
- Muhammad Mohyuddin
- Manavotam Singh (ORCID: https://orcid.org/0000-0002-9661-0297)
- Meena Chatrathi
- Tania Vora
- Kriti Kalra (ORCID: https://orcid.org/0000-0001-5753-8301)
- F. Sheikh
- Francisca Bermudez (ORCID: https://orcid.org/0009-0000-2922-9210)
- Anirudh Rao
- M.E. Rodrigo
- Hasan Javed
- Alex Tabone
- Jiling Chou
- Sara Ahmed
- Keki Balsara
- Richa Gupta
Institutions
- Sutter Health (US)
- MedStar Washington Hospital Center (US)
- Georgetown University (US)
- East Carolina University (US)
- Alaska Heart and Vascular Institute (US)
- University of Arkansas for Medical Sciences (US)
- MedStar Health (US)
Publication Details
- Journal
- Journal of Cardiac Failure - Intersections
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1016/j.yjcafi.2025.12.006
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00